Amazon (AMZN) Pharmacy Introduces RxPass
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Amazon (AMZN) to face challenges as COVID-fueled growth normalizes
January 24, 2023 10:08 AM ESTTelsey Advisory Group reiterated an Outperform rating on Amazon.com (NASDAQ: AMZN) but cut the price target on the e-commerce company to $125.00 (From $140.00) ahead of its 4Q22 earnings release scheduled for Thursday, February 2nd.
Telsey reduced their 4Q22 and 2023 outlook on the company to reflect a more challenging consumer and corporate spending environment. The company is facing headwinds in the form of a normalizing... More



